SCHOTT Pharma AG & Co. KGaA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A3ENQ51
EUR
22.40
-6.25 (-21.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
SCHOTT Pharma AG & Co. KGaA

Why is SCHOTT Pharma AG & Co. KGaA ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 14.13%
  • Poor long term growth as Net Sales has grown by an annual rate of 3.83% and Operating profit at 0.75% over the last 5 years
  • The company is Net-Debt Free
2
With ROE of 15.26%, it has a Very Expensive valuation with a 2.70 Price to Book Value
  • Over the past year, while the stock has generated a return of -8.61%, its profits have fallen by -5.6%
3
Underperformed the market in the last 1 year
  • Even though the market (Germany DAX (TR)) has generated returns of 8.94% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -8.61% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is SCHOTT Pharma AG & Co. KGaA for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
SCHOTT Pharma AG & Co. KGaA
-100.0%
-0.56
32.96%
Germany DAX (TR)
9.59%
0.53
16.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.83%
EBIT Growth (5y)
0.75%
EBIT to Interest (avg)
12.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0
Tax Ratio
23.88%
Dividend Payout Ratio
18.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.40%
ROE (avg)
3,051.88%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
2.70
EV to EBIT
14.87
EV to EBITDA
9.90
EV to Capital Employed
2.75
EV to Sales
2.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.52%
ROE (Latest)
15.26%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend